NDUFS7

Across TCGA pan-cancer cohorts, NDUFS7 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of NDUFS7’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where NDUFS7 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types NDUFS7 is over-expressed in tumor, although a few such as CCRCC and COAD show the opposite, repressed pattern.

CCRCC, COAD, and HNSC are the cancer types where NDUFS7 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFS7 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	All	−1.457	<.001	12	view →
COAD	All	IV	−0.604	<.001	12	view →
HNSC	All	II,III,IV	−0.573	<.001	8	view →
LUAD	Male	All	+0.256	<.001	8	view →
LSCC	Male	All	+0.279	<.001	7	view →
PDAC	Female	All	−0.529	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

NDUFS7–CCRCC

Open the CCRCC breakdown →